Thursday - July 30, 2026
Paul Hastings Secures Victory for Kyverna Therapeutics in the Northern District of California
March 25, 2026
LOS ANGELES, California, March 25 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:

* * *

Paul Hastings Secures Victory for Kyverna Therapeutics in the Northern District of California

*

Paul Hastings LLP secured a victory for Kyverna Therapeutics (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies to treat patients with autoimmune diseases, in the Northern District of C . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products